“People that suspect they have endometriosis or suspect they have some sort of chronic disease, they always have to advocate for themselves, and that’s a crappy position to be in when you’re in terrible amounts of pain,” she says. “You feel defeated. You’ve been told it’s all in your head or whatever, and then you’re supposed to have the fortitude to keep trying to find doctors who might tell you that you’re crazy again.” -Diana Falzone Did you know that One in three women have conditions caused by poor ovarian health. Despite often debilitating symptoms, such conditions are still being treated with hormonal interventions introduced more than 50 years ago. The problem doesn’t stop there. Because the ovary plays a critical role in overall endocrine function, women experience serious health problems?when ovarian function fails. This is why Celmatix is working to transform women’s lives through better ovarian health. Women deserve better! CC: Endometriosis Foundation of America
Celmatix
生物技术研究
New York,NY 6,334 位关注者
A preclinical-stage women’s health biotech focused uniquely on ovarian biology.
关于我们
Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Celmatix’s proprietary multi-omic ovarian health platform, the world’s largest of its kind, is the foundation of the company’s novel pipeline of first-in-class therapies. For more information visit www.celmatix.com.
- 网站
-
https://www.celmatix.com
Celmatix的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- New York,NY
- 类型
- 私人持股
- 创立
- 2009
- 领域
- Reproductive Biology and Medicine、Genomics、Bioinformatics、Biotech、Women's health和Drug Development
地点
-
主要
14 Wall Street
US,NY,New York,10005
Celmatix员工
-
Mark Wolters
Independent Business Development Executive, Biopharmaceutical Industry
-
? Ardy Arianpour ?
CEO & Co-Founder @ SEQSTER | Global HealthTech Leader & Speaker | Life Sciences and Healthcare Innovator
-
Lei Tan
Senior Manager, Medical Communications at Celmatix
-
Rebecca Urbelis
Experienced product manager with a passion for healthtech
动态
-
What better way to celebrate Menopause Awareness Month than by congratulating Jessica Shepherd, MD, MBA, FACOG, on the release of her new book, Generation M! ???? Flow Space/ SHE Media hosted a fantastic event to mark the occasion! In Generation M, Dr. Jessica Shepherd, a board-certified OB/GYN and women's health advocate, provides an empowering and holistic approach to navigating perimenopause and menopause. Drawing from conversations with experts (including our CEO/ Founder Piraye Beim!) in nutrition, fitness, and meditation, as well as those experiencing these life stages, she offers scientifically backed advice and evidence-based recommendations to help women thrive. The book covers medical research, hormone replacement therapy (HRT), and practical tips for managing exercise, diet, sleep, and mindfulness, all delivered in a relatable and sometimes humorous tone. It equips women with tools to maintain vitality and well-being during this transitional phase. Buy your copy now! https://lnkd.in/ddvA9vER
-
October is Menopause Awareness Month! Check out our our CEO Piraye Beim's interview in Oprah Daily: "Many people consider menopause, which is when the ovary stops functioning, to be a natural phenomenon. But the reality is that it’s a completely modern phenomenon, and it’s a consequence of how successful we’ve been in other aspects of healthcare. A hundred years ago, most women died before the age of 50 with a fully functioning ovary. Now, the average life span for a woman in the United States is over 80. Given the ovary stops functioning around 50, that means that not only are we outliving our ovarian function, but we’re outliving it by decades. We can’t just normalize menopause and consider it a natural phenomenon that’s a rite of passage. We have to see it for what it is, which is a public health crisis, the end of the function of a critical, vital organ."
What If We Could Opt Out of Menopause Entirely?
oprahdaily.com
-
Did you know the number of women in the military is steadily increasing? They courageously serve despite the fact that their bodies and especially their ovaries, are disproportionately impacted by toxic exposures during active duty. "Investing in women's health research and evidence-based care is critical to meeting the health care needs of the women served by DoD. The DoD provides medical care to more than 230,000 active-duty Service women, nearly 2 million women military retirees, and to the family members of the active force and of retirees. Compared to men, this population experiences more than twice the rate of conditions in hematological, genitourinary, endocrine, nutrition, and immunity-related disorder categories. Additionally, women's rates for illness and injury-specific diagnoses, such as those associated with the musculoskeletal system and connective tissue, are more than 1.5 times those of male rates. DoD's systematic surveillance and research of health conditions among Service women at a population level will bolster treatment options, improve patient care, and support breakthrough technologies and resources for women inside and outside of the military health system. Information on specific DoD policy efforts can be found below." We are proud of the work we are doing to advocate, raise awareness, and create a better future for women!
DoD Commits $500 Million for Women's Health Research, Supports Better Care for All Women
defense.gov
-
We kicked off the week in Boston at the Women's Health Innovation Summit! Our CEO + Founder Piraye Beim was invited to speak on ovarian health alongside Ivana Muncie-Vasic, CEO + Founder at Vitra Labs and Anne Morrissey, CEO of May Health. Thank you Sandy Milligan, MD JD, President of Aspira Women's Health for a great conversation! Let's see what ovarian health looks like in 10 years ?? Ft: Liz Powell Katie Collins Madeline Stickley Ariel Kramer
-
“The average age of menopause has stayed constant over the years, but women are living decades longer than that because of health and medical advances,” said corresponding author?Francesca Duncan, associate professor of obstetrics and gynecology (reproductive science in medicine) at Northwestern University Feinberg School of Medicine. “We’ve changed the landscape of how we live, and our ovarian function needs to catch up so that we have an organ that functions proportionately to maintain women’s health spans longer.” While this drug can't be used in a clinical setting, it's very exciting to see progress made on this front to improve ovarian function. Women deserve better! Great work by ?Francesca Duncan associate professor of obstetrics and gynecology (reproductive science in medicine) at Northwestern University - The Feinberg School of Medicine and her team.
New treatment extends ovarian function in older mice
eurekalert.org
-
Are you heading to the Women's Health Innovation Summit in a couple weeks? Our CEO + Founder, Piraye Beim PhD, will be speaking on the panel "Ovarian Health: Unlocking The Future of Holistic Hormone Health" with Sandy Milligan, MD JD, President of Aspira Women's Health and Ivana Muncie-Vasic, CEO & Founder of Vitra Labs. This discussion highlights the latest developments and research-to-date around ovarian function. Looking at the hormones that dominate the endocrine system, this panel assesses the broader impact that an understanding of ovarian function would have on extending fertility, delaying menopause, and significantly reducing symptoms such as sweating, heart disease and dementia experienced by women throughout their lifetime. See you there! #womenshealth #ovarianhealth #femtech #whis #whis2024
-
“I think understanding how sex influences biological processes in the brain that lead to Alzheimer’s and dementia can help us identify therapies that would work best for women,” said Sepideh Shokouhi assistant professor of psychiatric and behavioral sciences at Vanderbilt University Medical Center.
PCOS linked to cognitive and heart health risks
click2houston.com
-
This alarming and unfortunate statistic is a reminder of the dire need for new, innovative, and affordable fertility treatments. #fertility #womenshealth #menshealth #infertility
-
New discovery in Female Reproductive Health! A recent study published in Nature Genetics reveals that a rare genetic variant in the CCDC201 gene significantly impacts women's reproductive health. Researchers found that women who are homozygous for a stop-gain variant in CCDC201 experience menopause 9 years earlier on average, with nearly half developing primary ovarian insufficiency (POI) by age 40. Read more here: https://lnkd.in/dfjzT_76 Congratulations to the researchers ásmundur Oddsson,?Valgerdur Steinthorsdottir,?Gudjon Oskarsson,?Unnur Styrkarsdottir,?Kris Moore,?Salv?r ísberg,?Gísli Halldórsson,?Gardar Sveinbjornsson,?David Westergaard,?Henriette Svarre Nielsen,?Run Fridriksdottir,?Brynjar Jensen,?Gudny Anna Arnadottir,?Hákon Jónsson,?Arni Sturluson,?Audunn Snaebjarnarson,?Ole Andreassen,?G. Bragi Walters,?Mette Nyegaard,?Christian Erikstrup,?Thora Steingrimsdottir,?Rolv Terje Lie,?Páll Melsted,?Ingileif Jonsdottir, and Kari Stefansson on this monumental new discovery!
Homozygosity for a stop-gain variant in CCDC201 causes primary ovarian insufficiency - Nature Genetics
nature.com